The lead antibody is in Phase 2 studies for asthma, COPD and atopic dermatitis; a fourth study is planned, with data from all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results